HCAL
DMAC icon

HURRICANE CAPITAL ADVISORS LLC’s DiaMedica Therapeutics DMAC Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Hold
67,472
– – 0.12% 177
2026
Q1 		$457K Buy
+67,472
New +$535K 0.14% 123

Other funds holding DMAC

Cooperman Leon G
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HURRICANE CAPITAL ADVISORS LLC's DMAC Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 67,472 shares worth $475K. The position accounts for 0.12% of the portfolio, ranked #177.

HURRICANE CAPITAL ADVISORS LLC first reported a position in DMAC in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 67,472 shares of DiaMedica Therapeutics worth $475K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up 0.12% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #177 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in DiaMedica Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.